ABSTRACT: There is a clinical need for imaging technologies that can accurately detect cell death in a multitude of pathological conditions. Zinc(II)-bis(dipicolylamine) (Zn 2 BDPA) coordination complexes are known to associate with the anionic phosphatidylserine that is exposed on the surface of dead and dying cells, and fluorescent monovalent Zn 2 BDPA probes are successful cell death imaging agents. This present study compared the membrane targeting ability of two structurally related deep-red fluorescent probes, bis-Zn 2 BDPA-SR and tetra-Zn 2 BDPA-SR, with two and four appended Zn 2 BDPA units, respectively. Vesicle and cell microscopy studies indicated that a higher number of Zn 2 BDPA targeting units improved probe selectivity for phosphatidylserine-rich vesicles, and increased probe localization at the plasma membrane of dead and dying cells. The fluorescent probes were also tested in three separate animal models, (1) necrotic prostate tumor rat model, (2) thymus atrophy mouse model, and (3) traumatic brain injury mouse model. In each case, there was more tetra-Zn 2 BDPA-SR accumulation at the site of cell death than bis-Zn 2 BDPA-SR. The results indicate that multivalent Zn 2 BDPA probes are promising molecules for effective imaging of cell death processes in cell culture and in living subjects.
■ INTRODUCTION
Cell death is a critical process for maintaining normal development and preventing the onset of pathological conditions. 1,2 Disruption of homeostasis, either by excessive or deficient cell death, has been linked to cancer, neurodegenerative disorders, cardiovascular diseases, and autoimmune diseases. 3−5 There is an ongoing research effort to develop imaging and diagnostic agents that can target and identify dead and dying cells, with the goal of producing detection technologies that can evaluate the status of disease or the efficacy of therapeutic intervention. In the case of in vivo imaging, various strategies have been developed to target either intracellular or extracellular biomarkers of cell death. 6 One approach is to utilize protein or small molecule imaging probes that have selective affinity for the anionic phospholipid, phosphatidylserine (PS), which is exposed on the plasma membrane surface during cell death processes. 7 We have contributed by developing synthetic molecular probes that are equipped with zinc(II)-bis(dipicolylamine) (Zn 2 BDPA) coordination complexes as PS targeting units. 8−12 The membrane association is mediated by coordination of the probe's zinc cations with the oxyanion groups in the PS headgroup. Successful in vivo optical imaging of cell death using fluorescent Zn 2 BDPA probes has been demonstrated in a variety of animal models, although probe doses have been fairly high because the probes only have moderate affinity for membrane surfaces with exposed PS (low micromolar dissociation constants). 13 In principle, one way to enhance membrane targeting is to employ multivalency, which has been defined as the interaction of multiple recognition elements on a single scaffold with multiple receptors on a separate system. 14 Multivalent interactions are found extensively in membrane biology and are especially important for recognition and attachment of pathogens to host cells. 15, 16 The protein Annexin V exhibits highly selective targeting of anionic cell membranes; due in part to a strong multivalent effect produced by the four repeat units in its molecular structure. 17 With this structural precedence in mind, we decided to prepare fluorescent molecular probes that are appended with multiple copies of Zn 2 BDPA targeting units and determine if they act as improved cell death imaging agents. Recently, we invented squaraine rotaxanes (SR) as a novel class of highly stable and extremely bright fluorescent dyes with deep-red emission wavelengths (650−750 nm) and high suitability for whole-body fluorescence imaging. 18, 19 The favorable optical properties are due to the interlocked molecular architecture that surrounds the squaraine fluorophore with a protective macrocycle. We have also developed synthetic methods for attaching multiple targeting groups to a central squaraine rotaxane scaffold and creating multivalent fluorescence imaging probes. 20 Here, we compare the targeting and imaging performance of three squaraine rotaxane probes, the tetravalent tetra-Zn 2 BDPA-SR, the divalent bis-Zn 2 BDPA-SR, and nontargeted tracer-653 (Figure 1 ). The probes have nearly identical deep-red emission wavelengths that facilitate studies using spectroscopic assays, cell microscopy, and small animal models. Evaluating the same probe molecules in these different experimental settings is an important technical advantage that simplifies data comparison. We have determined probe selectivity for vesicle membranes containing PS and also evaluated ability to target and image cell death in cell culture and in living animal models. We find that increasing the number of Zn 2 BDPA targeting groups improves probe selectivity for PS-rich vesicle membranes, increases probe localization at the plasma membrane of dead and dying cells, and enhances in vivo optical imaging performance in three rodent models of cell death.
■ MATERIALS AND METHODS
Materials. Culture media and bovine serum albumin (BSA) were purchased from Sigma Aldrich. MDA-MB-231 (ATCC: HB-26) and A549 (ATCC: CCL-185) cells were certified and obtained from the ATCC. POPC (1-palmitoyl-2-oleoyl-snglycero-3-phosphocholine) and POPS (1-palmitoyl-2-oleoyl-snglycero-3-phosphoserine) were purchased from Avanti Polar Lipids and stored in CHCl 3 at −20°C. DilC 18 (1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate) was purchased from Invitrogen Inc. The syntheses of tetraZn 2 BDPA-SR, bis-Zn 2 BDPA-SR, tracer-653, and Zn 2 BDPA have been reported previously. 21−24 The three squaraine rotaxane probes absorb at ∼653 nm and emit at ∼672 nm with essentially the same quantum yield and high chemical stability.
Vesicle Preparation. An appropriate mixture of phospholipid was dried as a film under vacuum for 1 h. A stock solution of vesicles (10 mM phospholipid) was made by rehydration with HEPES buffer (10 mM HEPES, 137 mM NaCl, 3.2 mM KCl, pH 7.4) at room temperature. Multilamellar vesicles were converted to unilamellar vesicles by extruding 21 times through a polycarbonate Nucleopore filter with 200 nm diameter pores using a Basic LiposoFast device (Avestin).
FRET Titrations. Small aliquots of fluorescent probe stock solution (0.25 mM in HEPES buffer) were added incrementally to a dispersion of vesicles (10 μM total phospholipid, HEPES buffer, pH 7.4) under constant stirring at 25°C. After each addition, a fluorescence spectrum was acquired from 500 to 750 nm with excitation at 480 nm. The changes in DilC 18 fluorescence intensity at 567 nm were plotted, and the curves for bis-Zn 2 BDPA-SR binding were fitted using the "one site total" nonlinear regression algorithm within the program Graphpad Prism 5. The curves for tetra-Zn 2 BDPA-SR binding did not fit to any standard association model.
Cell Microscopy. Brightfield and fluorescence microscopy was performed on a Nikon TE-2000U epi-fluorescence microscope equipped with a Cy5 filter (ex, 620/60; em, 700/ 75). Fluorescence images were captured using Metamorph software (Universal) and analyzed using ImageJ.
MDA-MB-231 cells were seeded onto a chambered coverslip system. Once the cells reached 80% confluency, etoposide (15 μM) was added to the cells and allowed to incubate at 37°C for 11 h. The media was removed and different probe concentrations were added to the wells, followed by HEPES buffer. The cells were incubated at 37°C for 30 min, washed three times with HEPES buffer, then imaged by fluorescence microscopy. A549 lung carcinoma cells were subjected to the same protocol except they were stained with only tetraZn 2 BDPA-SR.
For the vesicle cold block study, MDA-MB-231 cells were seeded onto a chambered coverslip system, and once 80% confluency was reached, they were treated with etoposide (15 μM) at 37°C for 11 h. The media was removed and replaced with HEPES buffer. Tetra-Zn 2 BDPA-SR (1 μM) was added to the cells along with 100-fold excess of either POPC/POPS (50:50) or POPC liposomes. The cells were incubated at 37°C for 30 min, washed three times with HEPES buffer, then imaged by fluorescence microscopy.
Animal Imaging. All animal handling and imaging procedures were approved by the University of Notre Dame Institutional Animal Care and Use Committee. Epifluorescence animal images were acquired using a Carestream Health In Vivo Multispectral Imaging System FX equipped with 630 ± 10 nm excitation and 700 ± 20 nm emission filter set.
Prostate Tumor Rat Models. Subcutaneous Prostate Tumor Rat Model. Eight-week old Lobund-Wistar rats (Freimann Life Science Center; 250 g, n = 4) were injected subcutaneously into the right flank with 1 × 10 6 Prostate Adenocarcinoma III (PAIII) cells suspended in 300 μL of DMEM medium. Tumors grew for 14 days prior to probe dosing and imaging. The rats were anesthetized (1.5% isoflurane inhalation) and injected intravenously via the tail vein with 20 nmol of tetra-Zn 2 BDPA-SR, bis-Zn 2 BDPA-SR, or tracer-653 in water. Twenty-four hours after probe injection, the rats were anesthetized and sacrificed. The skin covering the flank of each rat was removed before whole-body fluorescence imaging.
Spontaneous Prostate Tumor Rat Model. A cohort of 3−4 month old Lobund-Wistar rats (n = 3) were injected intravenously with N-methyl-N-nitrosourea (MNU, 30 mg/ kg) followed by subcutaneous implantation of testosterone propionate (25 mg) pellets at 7, 60, and 120 d post-MNU injection. Once prostate tumors were palpable (typically by 10−12 months of age), the rats were injected intravenously via the tail vein with tetra-Zn 2 BDPA-SR (20 nmol). Twenty-four hours postinjection, the rats were euthanized by CO 2 asphyxiation and the skin overlying the pelvic-abdominal region was removed to facilitate whole-body fluorescence imaging. Selected tissues were excised and placed on a transparent imaging tray for ex vivo fluorescence imaging.
Thymus Atrophy Mouse Model. Six cohorts of 8-week old male immunocompetent hairless mice (SKH-1, Freimann Life Science Center, ∼25 g) (n = 4) were given intraperitoneal injections (50 mg/kg) of water-soluble dexamethasone (Sigma Aldrich) dissolved in 100 μL of distilled water. The time from dexamethasone dosing to sacrifice of the cohort (and its related control cohort) was 42 h with injection of fluorescent probe at 24 h before sacrifice. The fluorescent probe (20 nmol of tetraZn 2 BDPA-SR, bis-Zn 2 BDPA-SR, or tracer-653 in water) was injected intravenously via the tail vein. Three additional cohorts of mice (n = 4) were not treated with dexamethasone but were injected with fluorescent probe (tetra-Zn 2 BDPA-SR, bisZn 2 BDPA-SR, or tracer-653). All animals were euthanized by either CO 2 asphyxiation or cervical dislocation under anesthesia. After sacrifice, selected tissues were excised and placed on a transparent imaging tray for ex vivo fluorescence imaging.
Traumatic Brain Injury Mouse Model. Three cohorts of 4−6 week old immunocompetent hairless mice (male, ∼25 g, SKH-1) (n = 5) were anesthetized by 2% isoflurane inhalation. A metal cylinder, with a 3 mm diameter, was precooled in liquid nitrogen and applied to the parietal region of each mouse's head for 60 s. The mice then received a 20 nmol intravenous injection of tetra-Zn 2 BDPA-SR, bis-Zn 2 BDPA-SR, or tracer-653, and whole-body epi-fluorescence images were acquired immediately after probe injection and at 3, 6, and 24 h time points. For Zn 2 BDPA cold block studies, immunocompetent hairless mice (SKH-1, ∼25 g, n = 4) were administered a solution of either Zn 2 BDPA in 100 μL of 10% DMSO/H 2 O or vehicle control (100 μL of 10% DMSO/H 2 O) immediately after cryoinjury. Thirty minutes was allowed to elapse, then the mice were injected retro-orbitally with 20 nmol of either tetraZn 2 BDPA-SR or bis-Zn 2 BDPA-SR. The concentration of Zn 2 BDPA was 15-fold higher than the effective concentration of Zn 2 BDPA units on the multivalent tetra-Zn 2 BDPA-SR and bis-Zn 2 BDPA-SR probes. After twenty-four hours, the mice were anesthetized, sacrificed, and the brains were excised for ex vivo fluorescence imaging.
Fluorescence Image Analysis. Images were analyzed using ImageJ software. The 16-bit images were imported, opened in sequential order, and converted to an image stack. Background subtraction was applied to the images using the rolling ball algorithm. The stack was then converted to a montage and pseudocolored as "Thai" (under the "Lookup Tables" menu) . Region of interest (ROI) analysis was performed on each in vivo and ex vivo image by drawing an area around the Target (T) and a same sized area around a suitable Non-Target (NT) location. For the in vivo tumor imaging studies, the NT site was the contralateral flank, and for the in vivo traumatic brain injury studies, the NT site was on the lower back of the animal. The mean pixel intensities for T and NT regions were measured and plotted using Graphpad Prism 4. For ex vivo biodistribution images, ROI analysis of each excised tissue produced a mean pixel intensity. For the Traumatic Brain Injury study, I/I o values for the cryoinjury were calculated by measuring the mean pixel intensities at each time point (I) and dividing by the mean pixel intensities at the initial time point (I o ).
Statistical Analysis. Results are depicted as mean ± standard error of the mean (SEM). Statistical analysis was performed using a Student's t test.
■ RESULTS
A fluorescence resonance energy transfer (FRET) titration assay was developed to enable direct comparison of probe binding to vesicles with membrane compositions that mimicked the plasma membranes of healthy cells (zwitterionic POPC only) or dead/dying cells (mixture of POPC and anionic POPS). In each case, the vesicles contained 1 mol % of the lipophilic fluorescence energy donor dye DiIC 18 that is excited at 480 nm and emits at 570 nm. 25 Association of squaraine rotaxane probe (acting as FRET acceptor) to the vesicle surface leads to quenching of the DiIC 18 emission ( Figure S1 , Supporting Information). The titration plots in Figure 2a show that bis-Zn 2 BDPA-SR has moderate affinity for POPC vesicles (K d = 0.43 ± 0.04 μM) and slightly higher affinity for POPC/POPS vesicles (K d = 0.15 ± 0.02 μM). In comparison, the tetra-Zn 2 BDPA-SR with its greater positive charge and increased hydrophilicity exhibited a much higher selectivity for the anionic POPC/POPS vesicles over zwitterionic POPC vesicles (Figure 2b ). Quantitative analysis of the tetraZn 2 BDPA-SR titration curves was not possible due to the very weak association with the POPC vesicles and precipitation of the cross-linked POPC/POPS vesicles in the later stages of the titration, but qualitatively, the curves show that the higher selectivity exhibited by tetra-Zn 2 BDPA-SR (compared to bisZn 2 BDPA-SR) is not due to an increase in POPC/POPS affinity but instead to substantially reduced POPC affinity. As expected, the control probe, tracer-653, had negligible interaction with the vesicles (Figure 2c) .
Cell microscopy studies primarily employed cultures of MDA-MB-231 breast cancer cells, and cell death was induced by preliminary treatment with etoposide, a topoisomerase inhibitor. 26 As expected, the tracer-653 did not associate with healthy or dead cells. The tetra-Zn 2 BDPA-SR and bisZn 2 BDPA-SR also did not stain healthy cells, but both probes selectively targeted dead and dying cells ( Figure S2 , Supporting Information). As shown in Figure 3 , there was a marked difference in cell distribution; the tetra-Zn 2 BDPA-SR localized strongly at the plasma membrane, whereas the bis-Zn 2 BDPA-SR distributed throughout the cytosol. Additional multicolor fluorescence imaging studies included the blue-emitting, nucleic acid stain, SYTOX Blue. Since the dye is membrane impermeable, it only stains necrotic cells that have a compromised plasma membrane. As illustrated in Figures 4 and S3, Supporting Information, the staining combination observed with a binary mixture of Zn 2 BDPA probe and SYTOX Blue allowed distinction of healthy, apoptotic, and necrotic cells.
The strong localization of tetra-Zn 2 BDPA-SR at the plasma membrane enabled high contrast imaging of dead and dying cells at significantly lower concentrations than the 10 μM that is typically used for monovalent Zn 2 BDPA fluorescent probes. Indeed, effective plasma membrane staining of dead/dying MDA-MB-231 cells and also A549 lung carcinoma cells was observed using tetra-Zn 2 BDPA-SR at the low concentration of 500 nM ( Figure S4, Supporting Information) . Moreover, the staining with tetra-Zn 2 BDPA-SR allowed visualization of apoptotic bodies that were external to the cell surface.
Evidence that dead/dying cell staining by tetra-Zn 2 BDPA-SR was a membrane targeting process was gained by conducting a cold block study that used vesicles to competitively inhibit association of tetra-Zn 2 BDPA-SR to etoposide-treated MDA-MB-231 cells. As seen in Figure S5a , Supporting Information, a 100-fold excess of POPC and POPC/POPS (1:1) vesicles inhibited tetra-Zn 2 BDPA-SR staining of cell death. Quantification of the fluorescence micrographs ( Figure S5b , Supporting Information) confirmed that POPC/POPS vesicles were more effective than the POPC vesicles at blocking cell targeting of tetra-Zn 2 BDPA-SR, in agreement with the probe/vesicle affinity differences noted in Figure 2 .
Repeated attempts were made to evaluate the cell staining by flow cytometry. Separate samples of healthy and etoposidetreated MDA-MB-231 cells were incubated with various concentrations of bis-Zn 2 BDPA-SR or tetra-Zn 2 BDPA-SR and then the cells were released into solution by treatment with trypsin. Histograms of the cells treated with bis-Zn 2 BDPA-SR consistently showed selective staining of a population of dead/ dying cells induced by the etoposide. However, consistent flow cytometry data could not be gained when the cells were treated with tetra-Zn 2 BDPA-SR. The major technical problem was cross-linking of the dead/dying cells after treatment with trypsin, an observation that is consistent with the probeinduced precipitation of POPC/POPS vesicles described above, and also with the cell fluorescence images in Figure 3 showing extensive localization of the tetra-Zn 2 BDPA-SR at the surface of the dead/dying cells. We conclude that the multivalent tetraZn 2 BDPA-SR is a highly effective fluorescent probe for staining dead/dying cells that are adhered to surfaces, but it is problematic for analyses of cells or vesicles that are dispersed in solution due to cross-linking effects.
The in vivo targeting abilities of the probes were evaluated in three different animal models of cell death that we have previously shown can be imaged using fluorescent Zn 2 BDPA probes. The first study used two versions of a prostate tumor rat model that is known to develop necrotic foci. 9 A subcutaneous tumor model was created by injecting PAIII prostate cancer cells subcutaneously into the flanks of LobundWistar rats and allowing them to grow for 14 days to ensure that areas of cell death had developed within the tumor. Rats were then injected with 20 nmol of tetra-Zn 2 BDPA-SR, bisZn 2 BDPA-SR, or tracer-653. After 24 h, the rats were sacrificed, and the skin covering the flanks of the rats was removed to allow semiquantitative imaging of probe accumulation within the tumors. As seen in Figure 5a , tumors were easily visualized as target sites (T) in animals injected with tetra-Zn 2 BDPA-SR and bis-Zn 2 BDPA-SR, while tracer-653 showed minor tumor accumulation. Region of interest (ROI) analysis showed that the tetra-Zn 2 BDPA-SR had the highest T/NT value (8.57 ± 1.67) compared to bis-Zn 2 BDPA-SR (4.22 ± 0.28) and tracer-653 (2.56 ± 0.21) (Figure 5b ). An additional set of imaging studies using a more clinically relevant spontaneous prostate tumor rat model showed similar high tumor accumulation of tetra-Zn 2 BDPA-SR ( Figure S6, Supporting Information) .
The second animal model study used immunocompetent mice with intraperitoneal injections of dexamethasone to induce extensive thymocyte cell death and thymus atrophy. 11,27−29 The model is technically straightforward to conduct, with excellent reproducibility and high animal throughput, making it an ideal animal model for validating cell death imaging probes. Tetra-Zn 2 BDPA-SR, bis-Zn 2 BDPA-SR, and tracer-653 were injected intravenously into mice at 18 h after treatment with dexamethasone or vehicle control, and the mice were sacrificed at 24 h after probe injection. Images of the excised thymi and the corresponding mean pixel intensities determined by ROI analysis are shown in Figure 6 . The average mean pixel intensity for tetra-Zn 2 BDPA-SR accumulation in the thymi taken from treated animals was 2.5-and 5.5-fold greater than bis-Zn 2 BDPA-SR and tracer-653, respectively. Moreover, both Zn 2 BDPA fluorescent probes exhibited higher accumulation than tracer-653 in thymi from nontreated control mice, consistent with the probe's better ability to target basal levels of thymocyte cell death.
The third animal study was a model of traumatic brain injury that induced rapid breakdown of the blood−brain barrier and tissue damage via application of a precooled rod to the head of a mouse.
12,30−32 In short, three separate cohorts of immunocompetent mice (n = 4) were anesthetized by isoflurane inhalation. A metal cylinder with a 3 mm diameter was precooled in liquid nitrogen and applied to each mouse's head for 60 s. The mice were injected intravenously with tetraZn 2 BDPA-SR, bis-Zn 2 BDPA-SR, or tracer-653 and subjected to in vivo epi-fluorescence imaging at 0, 3, 6, and 24 h after probe dosage. The in vivo images showed early accumulation of tetraZn 2 BDPA-SR and bis-Zn 2 BDPA-SR at the site of cryoinjury and rapid clearance of tracer-653 ( Figure S5 , Supporting Information). Quantitative ROI analysis of the in vivo images showed that tetra-Zn 2 BDPA-SR and bis-Zn 2 BDPA-SR exhibited similar T/NT values over the first six hours ( Figure  S6 , Supporting Information), but at the 24 h time point, there were two apparent differences: (a) more of the tetra-Zn 2 BDPA-SR remained in the animal brain (Figures 7a and S7 , Supporting Information) and (b) T/NT for tetra-Zn 2 BDPA-SR (4.78 ± 0.33) at the site of cryoinjury was significantly higher than bis-Zn 2 BDPA-SR (2.12 ± 0.12) ( Figure S8 , Supporting Information). After the 24 h time point, the mice were anesthetized and sacrificed, and the brains were excised for ex vivo imaging. The brains from cryoinjured mice treated with tracer-653 showed weak and homogeneous staining. In contrast, the brains from cryoinjured mice dosed with tetraZn 2 BDPA-SR and bis-Zn 2 BDPA-SR showed localized staining at the injury site (Figure 7b ) with the tetra-Zn 2 BDPA-SR images producing higher mean pixel intensities suggesting higher probe concentration.
The importance of the Zn 2 BDPA affinity units for in vivo targeting was confirmed by a cold block experiment that inhibited probe accumulation at the site of cryoinjury. The cold block was achieved by administering a 15-fold molar excess dose of nonfluorescent Zn 2 BDPA (structure in Figure 1 ) immediately after cryoinjury. Thirty minutes was allowed to elapse before intravenous injection of tetra-Zn 2 BDPA-SR or bis-Zn 2 BDPA-SR, and the mice were sacrificed 24 h later. The Zn 2 BDPA cold block inhibited tetra-Zn 2 BDPA-SR and bisZn 2 BDPA-SR targeting by approximately 50% compared to a control dose of the vehicle ( Figure S10 , Supporting Information).
■ DISCUSSION
This study compared three fluorescent probes; bis-Zn 2 BDPA-SR with two Zn 2 BDPA units, tetra-Zn 2 BDPA-SR with four Zn 2 BDPA units, and tracer-653 (Figure 1) . The fluorescent squaraine rotaxane scaffold that is common to each probe is lipophilic, and previous studies have shown that it readily inserts into bilayer membranes. 21 Probe lipophilicity is diminished by attaching polar functional groups to the structural periphery. In the case of tracer-653, the high surface density of zwitterionic groups leads to negligible affinity for biological surfaces. 22 Membrane association of bis-Zn 2 BDPA-SR is driven by a combination of electrostatic and hydrophobic effects. There is considerable association with zwitterionic POPC vesicles and only three times higher affinity for anionic POPC/POPS vesicles. In comparison, the membrane targeting of tetra-Zn 2 BDPA-SR is dominated by electrostatic interactions, and although there is no apparent increase in probe affinity for POPC/POPS vesicles, there is greatly reduced affinity for POPC vesicles (Figure 2 ). This finding highlights an insightful point concerning the molecular design of multivalent Zn 2 BDPA probes. Increasing the number of cationic Zn 2 BDPA units may not necessarily increase a probe's affinity for anionic membranes because the structural change may produce a compensating loss in attractive hydrophobic probe/membrane interactions, but an increase in membrane selectivity is a generally expected outcome. In this present case, the structural change from divalent bis-Zn 2 BDPA-SR to tetravalent tetraZn 2 BDPA-SR greatly increased probe selectivity for PS-rich anionic vesicle membranes (mimic of dead/dying cells) over zwitterionic membranes (mimic of healthy cells).
The cell microscopy results showed that both cationic probes selectively targeted dead and dying cells over healthy cells, but the cell staining patterns reflected the inherent difference in membrane selectivity. The tetravalent tetra-Zn 2 BDPA-SR, with its eight zinc cations, localized strongly at the anionic plasma membranes of both apoptotic and necrotic cells and was an effective fluorescent stain even at submicromolar concentrations ( Figure S4, Supporting Information) . In contrast, the divalent bis-Zn 2 BDPA-SR distributed throughout the cytosol. The intracellular staining of necrotic cells was expected considering the high cell permeability and the modest membrane selectivity of the bis-Zn 2 BDPA-SR. An ability to penetrate the intact plasma membrane of apoptotic cells is notable but not a unique finding. A select group of small molecules is known to be transported by a channel protein that becomes activated during apoptosis. 33 The same channel transport process is unlikely to be operating here. Rather, the structure of bis-Zn 2 BDPA-SR has enough cationic charge and lipophilicity to selectively bind the anionic PS that is exposed on the surface of the apoptotic cell plasma membrane and subsequently diffuse through the membrane to the cytosol. We have observed this type of membrane permeation behavior before with related Zn 2 BDPA structures that have a similar mixture of moderate cationic charge and lipophilicity. 34 The three fluorescent probes were tested in three separate animal models of cell death, namely, necrotic prostate tumor rat model, thymus atrophy mouse model, and traumatic brain injury mouse model. Each animal model exhibits different cell death features with distinct pharmacokinetics and anatomical barriers; thus combined, the animal models provide a broad test of probe imaging performance. The cell death target sites for two of the models (rat prostate tumor and mouse thymus atrophy) were relatively deep inside the animal and noninvasive in vivo fluorescence imaging was not feasible. Thus, we imaged the animals at one time point, i.e., 24 h after sacrifice, with removal of the skin to improve image quantification (Figures 5  and 6 ). With both animal models, the imaging showed that the amount of probe accumulation at the site of cell death was tetra-Zn 2 BDPA-SR > bis-Zn 2 BDPA-SR ≫ tracer-653.
The third cell death model was a traumatic brain injury mouse model, and the superficial target site allowed longitudinal fluorescence imaging of living animals. Initially, all three probes localized rapidly to the site of brain injury due to passive diffusion through the disrupted blood−brain barrier. As expected, washout of tracer-653 was quite fast and complete within 1 h. After 24 h, there was almost complete clearance of bis-Zn 2 BDPA-SR, but a significant amount of tetra-Zn 2 BDPA-SR remained at the brain injury site (Figure 7 ). This result suggests that tetra-Zn 2 BDPA-SR has higher affinity for the dead and dying cells due to a slower rate of dissociation from the cell membrane surface. Support for this picture was gained from the ex vivo brain images, which were obtained 24 h after probe dosing (Figure 7b ). They showed tighter localization of tetraZn 2 BDPA-SR to the cryoinjury site than bis-Zn 2 BDPA-SR.
Inspection of the in vivo longitudinal images of mice with brain injury indicates that the tetra-Zn 2 BDPA-SR signal at the cryoinjury site increases significantly over the first three hours ( Figure S9, Supporting Information) . This imaging effect could be due to a temporal increase in cell death or to physiological changes caused by the local brain trauma such as increased perfusion or edema. However, these factors were ruled out in a previous study that noted the same imaging effect using a monovalent Zn 2 BDPA probe. 11 An alternative explanation considers the role of PS on the cell surface as a biomarker that triggers recognition and subsequent cell clearance by phagocytes. 35 PS-binding molecules such as Annexin V are known to inhibit the clearance of dead and dying cells by masking PS. 36 Thus, it is possible that Zn 2 BDPA probes can block dead cell clearance by the innate immune system, causing build up of fluorescent Zn 2 BDPA-labeled cells at the injury site. Additional studies are needed to test this immune modulation hypothesis. If correct, it raises the idea of masking PS with multivalent Zn 2 BDPA probes as a strategy to produce novel anticancer treatments. 37 
■ CONCLUSIONS
Zn 2 BDPA coordination complexes are known to associate with the PS that is exposed on the surface of dead and dying cells, and fluorescent monovalent Zn 2 BDPA probes act as cell death imaging agents. The results of this study support the general hypothesis that increasing the number of Zn 2 BDPA units appended to a fluorescent probe improves the probe's cell death targeting ability. Vesicle titration assays showed that tetra-Zn 2 BDPA-SR exhibited higher selectivity than bisZn 2 BDPA-SR for anionic POPC/POPS vesicles (mimic of dead/dying cell membranes) over zwitterionic POPC vesicles (mimic of healthy cell membranes). Cell microscopy studies demonstrated that both probes selectively targeted dead and dying cells, but there was a marked difference in cell distribution. The tetra-Zn 2 BDPA-SR localized strongly at the cell plasma membrane, whereas the bis-Zn 2 BDPA-SR distributed throughout the cytosol. The fluorescent probes were tested in three separate animal models, and in each case there was more tetra-Zn 2 BDPA-SR accumulation at the site of cell death than bis-Zn 2 BDPA-SR. Taken together, the results show that deep-red fluorescent multivalent Zn 2 BDPA-SR probes are effective optical imaging agents for visualizing cell death processes in cultured samples and living subjects.
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